Glover, Donna <br/><br/>
Phase II randomized trial of cisplatin and WR-2721 versus cisplatin alone for metastatic melanoma: an Eastern Cooperative Oncology Group Study (E1686).  [electronic resource] 

 -  Melanoma research  Dec 2003 
 - 619-26 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0960-8931 
<br/><br/><label>Standard No.: </label>10.1097/00008390-200312000-00012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amifostine--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Blood Pressure<br/>Body Weight<br/>Cisplatin--administration & dosage<br/>Female<br/>Humans<br/>Hypotension<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Radiation-Protective Agents--administration & dosage<br/>Time Factors<br/>Treatment Outcome